![David Lennon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Lennon
Directeur Général chez
WHITEHAWK THERAPEUTICS, INC.
Fortune : 3 M $ au 31/05/2026
Profil
Currently, David Lennon is President, Chief Executive Officer & Director at Whitehawk Therapeutics, Inc. since 2023 and Vice Chairman at Alliance for Regenerative Medicine since 2023.
Formerly, Dr. Lennon was Chief Executive Officer & Director at Satellite Biosciences, Inc. from 2021 to 2023, President at Novartis Gene Therapies, Inc. from 2020 to 2021, Managing Director & GM-Oncology Business at Novartis Pharma KK, President at Novartis AG, and Associate Principal at McKinsey & Co., Inc. Education includes a doctorate from Weill Cornell Medical College and an undergraduate degree from Columbia College (New York).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/05/2026 | 569 643 ( 1,21 % ) | 3 M $ | 31/05/2026 |
Postes actifs de David Lennon
| Sociétés | Poste | Début |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Directeur Général | 02/10/2023 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Directeur/Membre du Conseil | 21/10/2021 |
Anciens postes connus de David Lennon
| Sociétés | Poste | Fin |
|---|---|---|
Satellite Biosciences, Inc.
 Satellite Biosciences, Inc. BiotechnologyHealth Technology Provides shelf liver therapy services | Directeur Général | 01/09/2023 |
| AVEXIS INC | President | 01/07/2021 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
| NOVARTIS AG | President | - |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Directeur/Membre du Conseil | - |
Formation de David Lennon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Columbia College (New York)
 Columbia College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Provides shelf liver therapy services | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
